Papageorgiou General Hospital of Thessaloniki

Thessaloniki, Thessaloníki 56429

2 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, Breast Neoplasms, Hidradenitis Suppurativa, Neoplasm Metastasis, Obesity, Overweight, Pancreatic Ductal Adenocarcinoma, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. — Recruiting now
• A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors — Recruiting now
• A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Running, not enrolling
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) — Running, not enrolling
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes — Completed